| Year |
Citation |
Score |
| 2024 |
Hamel K, Moncada EL, Sheeler C, Rosa JG, Gilliat S, Zhang Y, Cvetanovic M. Cerebellar heterogeneity and selective vulnerability in spinocerebellar Ataxia type 1 (SCA1). Neurobiology of Disease. 106530. PMID 38750673 DOI: 10.1016/j.nbd.2024.106530 |
0.367 |
|
| 2024 |
Duvick L, Southern WM, Benzow KA, Burch ZN, Handler HP, Mitchell JS, Kuivinen H, Gadiparthi U, Yang P, Soles A, Sheeler CA, Rainwater O, Serres S, Lind EB, Nichols-Meade T, ... ... Cvetanovic M, et al. Mapping SCA1 regional vulnerabilities reveals neural and skeletal muscle contributions to disease. Jci Insight. PMID 38512434 DOI: 10.1172/jci.insight.176057 |
0.565 |
|
| 2023 |
Cvetanovic M, Gray M. Contribution of Glial Cells to Polyglutamine Diseases: Observations from Patients and Mouse Models. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 37020152 DOI: 10.1007/s13311-023-01357-5 |
0.38 |
|
| 2023 |
Duvick L, Southern WM, Benzow K, Handler HP, Mitchell JS, Kuivinen H, Gadiparthi UK, Yang P, Soles A, Scheeler C, Rainwater O, Shannah S, Larson E, Nichols-Meade T, You Y, ... ... Cvetanovic M, et al. Regional vulnerability in a neurodegenerative disease: Delineating SCA1 CNS and muscle therapeutic targets using a conditional mutant ATXN1 mouse. Biorxiv : the Preprint Server For Biology. PMID 36798410 DOI: 10.1101/2023.02.08.527710 |
0.56 |
|
| 2023 |
Rosa JG, Hamel K, Soles A, Sheeler C, Borgenheimer E, Gilliat S, Sbrocco K, Ghanoum F, Handler HP, Forster C, Rainwater O, Cvetanovic M. BDNF is altered in a brain-region specific manner and rescues deficits in Spinocerebellar Ataxia Type 1. Neurobiology of Disease. 178: 106023. PMID 36724861 DOI: 10.1016/j.nbd.2023.106023 |
0.347 |
|
| 2022 |
Handler HP, Duvick L, Mitchell JS, Cvetanovic M, Reighard M, Soles A, Mather KB, Rainwater O, Serres S, Nichols-Meade T, Coffin SL, You Y, Ruis BL, O'Callaghan B, Henzler C, et al. Decreasing mutant ATXN1 nuclear localization improves a spectrum of SCA1-like phenotypes and brain region transcriptomic profiles. Neuron. PMID 36577403 DOI: 10.1016/j.neuron.2022.11.017 |
0.566 |
|
| 2022 |
Borgenheimer E, Hamel K, Sheeler C, Moncada FL, Sbrocco K, Zhang Y, Cvetanovic M. Single nuclei RNA sequencing investigation of the Purkinje cell and glial changes in the cerebellum of transgenic Spinocerebellar ataxia type 1 mice. Frontiers in Cellular Neuroscience. 16: 998408. PMID 36457352 DOI: 10.3389/fncel.2022.998408 |
0.346 |
|
| 2022 |
Rosa JG, Hamel K, Sheeler C, Borgenheimer E, Gilliat S, Soles A, Ghannoum FJ, Sbrocco K, Handler HP, Rainwater O, Kang R, Cvetanovic M. Spatial and Temporal Diversity of Astrocyte Phenotypes in Spinocerebellar Ataxia Type 1 Mice. Cells. 11. PMID 36291186 DOI: 10.3390/cells11203323 |
0.319 |
|
| 2022 |
Yu D, Zarate N, White A, Coates D, Tsai W, Nanclares C, Cuccu F, Yue JS, Brown TG, Mansky RH, Jiang K, Kim H, Nichols-Meade T, Larson SN, Gundry K, ... ... Cvetanovic M, et al. CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington's disease. Acta Neuropathologica Communications. 10: 83. PMID 35659303 DOI: 10.1186/s40478-022-01379-8 |
0.358 |
|
| 2021 |
Sheeler C, Rosa JG, Borgenheimer E, Mellesmoen A, Rainwater O, Cvetanovic M. Post-symptomatic Delivery of Brain-Derived Neurotrophic Factor (BDNF) Ameliorates Spinocerebellar Ataxia Type 1 (SCA1) Pathogenesis. Cerebellum (London, England). PMID 33394333 DOI: 10.1007/s12311-020-01226-3 |
0.348 |
|
| 2019 |
Asher M, Rosa JG, Rainwater O, Duvick L, Bennyworth M, Lai RY, Kuo SH, Cvetanovic M. Cerebellar contribution to the cognitive alterations in SCA1: evidence from mouse models. Human Molecular Genetics. PMID 31696233 DOI: 10.1093/Hmg/Ddz265 |
0.391 |
|
| 2019 |
Ferro A, Sheeler C, Rosa JG, Cvetanovic M. Role of Microglia in Ataxias. Journal of Molecular Biology. PMID 30660620 DOI: 10.1016/J.Jmb.2019.01.016 |
0.393 |
|
| 2018 |
Mellesmoen A, Sheeler C, Ferro A, Rainwater O, Cvetanovic M. Brain Derived Neurotrophic Factor (BDNF) Delays Onset of Pathogenesis in Transgenic Mouse Model of Spinocerebellar Ataxia Type 1 (SCA1). Frontiers in Cellular Neuroscience. 12: 509. PMID 30718999 DOI: 10.3389/Fncel.2018.00509 |
0.482 |
|
| 2018 |
Kim JH, Lukowicz A, Qu W, Johnson A, Cvetanovic M. Astroglia contribute to the pathogenesis of spinocerebellar ataxia Type 1 (SCA1) in a biphasic, stage-of-disease specific manner. Glia. PMID 30043530 DOI: 10.1002/Glia.23451 |
0.518 |
|
| 2018 |
Ferro A, Qu W, Lukowicz A, Svedberg D, Johnson A, Cvetanovic M. Inhibition of NF-κB signaling in IKKβF/F;LysM Cre mice causes motor deficits but does not alter pathogenesis of Spinocerebellar ataxia type 1. Plos One. 13: e0200013. PMID 29975753 DOI: 10.1371/Journal.Pone.0200013 |
0.664 |
|
| 2017 |
Qu W, Johnson A, Kim JH, Lukowicz A, Svedberg D, Cvetanovic M. Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice. Journal of Neuroinflammation. 14: 107. PMID 28545543 DOI: 10.1186/S12974-017-0880-Z |
0.666 |
|
| 2016 |
Stanojlovic M, Pang X, Lin Y, Stone S, Cvetanovic M, Lin W. Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis. Plos One. 11: e0160158. PMID 27466819 DOI: 10.1371/Journal.Pone.0160158 |
0.383 |
|
| 2016 |
Cvetanovic M, Hu YS, Opal P. Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1. Cerebellum (London, England). PMID 27306906 DOI: 10.1007/S12311-016-0794-9 |
0.683 |
|
| 2016 |
Asher M, Johnson A, Zecevic B, Pease D, Cvetanovic M. Ataxin-1 regulates proliferation of hippocampal neural precursors Neuroscience. 322: 54-65. DOI: 10.1016/J.Neuroscience.2016.02.011 |
0.414 |
|
| 2015 |
Cvetanovic M, Ingram M, Orr H, Opal P. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1. Neuroscience. 289: 289-99. PMID 25595967 DOI: 10.1016/J.Neuroscience.2015.01.003 |
0.683 |
|
| 2015 |
Cvetanovic M. Decreased expression of glutamate transporter GLAST in Bergmann glia is associated with the loss of Purkinje neurons in the spinocerebellar ataxia type 1. Cerebellum (London, England). 14: 8-11. PMID 25255716 DOI: 10.1007/S12311-014-0605-0 |
0.429 |
|
| 2014 |
Venkatraman A, Hu YS, Didonna A, Cvetanovic M, Krbanjevic A, Bilesimo P, Opal P. The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1. Human Molecular Genetics. 23: 3733-45. PMID 24594842 DOI: 10.1093/Hmg/Ddu081 |
0.712 |
|
| 2012 |
Cvetanovic M, Kular RK, Opal P. LANP mediates neuritic pathology in Spinocerebellar ataxia type 1. Neurobiology of Disease. 48: 526-32. PMID 22884877 DOI: 10.1016/J.Nbd.2012.07.024 |
0.681 |
|
| 2011 |
Cvetanovic M, Patel JM, Marti HH, Kini AR, Opal P. Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1. Nature Medicine. 17: 1445-7. PMID 22001907 DOI: 10.1038/Nm.2494 |
0.65 |
|
| 2009 |
Kular RK, Cvetanovic M, Siferd S, Kini AR, Opal P. Neuronal differentiation is regulated by leucine-rich acidic nuclear protein (LANP), a member of the inhibitor of histone acetyltransferase complex. The Journal of Biological Chemistry. 284: 7783-92. PMID 19136565 DOI: 10.1074/Jbc.M806150200 |
0.666 |
|
| 2007 |
Cvetanovic M, Rooney RJ, Garcia JJ, Toporovskaya N, Zoghbi HY, Opal P. The role of LANP and ataxin 1 in E4F-mediated transcriptional repression. Embo Reports. 8: 671-7. PMID 17557114 DOI: 10.1038/Sj.Embor.7400983 |
0.69 |
|
| 2006 |
Mitchell JE, Cvetanovic M, Tibrewal N, Patel V, Colamonici OR, Li MO, Flavell RA, Levine JS, Birge RB, Ucker DS. The presumptive phosphatidylserine receptor is dispensable for innate anti-inflammatory recognition and clearance of apoptotic cells. The Journal of Biological Chemistry. 281: 5718-25. PMID 16317002 DOI: 10.1074/Jbc.M509775200 |
0.331 |
|
| 2004 |
Cvetanovic M, Ucker DS. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. Journal of Immunology (Baltimore, Md. : 1950). 172: 880-9. PMID 14707059 DOI: 10.4049/Jimmunol.172.2.880 |
0.333 |
|
| Show low-probability matches. |